Tim Boreham interviews Anatara CEO
Steve spoke with Tim about the Company's evolving story into the human health space, the growing concern around the use of antibiotics in agriculture and the opportunity a product like Detach presents. The discussion also covered how the Company is setting itself up to play in the expansive market for over-the-counter gastrointestinal and digestive products with its Gastrointestinal ReProgramming (GaRP) dietary supplement "a three pronged approach to bug busting".
Dr Boreham's Crucible: Anatara Lifesciences can be read here.
About Anatara Lifesciences Ltd
Anatara Lifesciences (ASX:ANR) is developing and commercialising innovative, evidence-based products for gastrointestinal health where there is significant unmet need. Anatara is a life sciences company with expertise in developing products for animal and human health. Anatara is focused on building a pipeline of human gastrointestinal health products. Underlying this product development program is our commitment to delivering real outcomes for patients and strong value for our shareholders. For more information, please visit www.anataralifesciences.com.
Anatara Lifesciences Ltd